KLRS compared with RANI: revenue, margins and what each company keeps, and the suppliers and customers both name

KLRSKalaris Therapeutics, Inc.

Mkt capRevenueRevenue

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

Compare

KLRSKalaris Therapeutics, Inc.

RANIRani Therapeutics Holdings, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

KLRS1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.76%—

RANI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.6%▼−0.23%×0.01

= impliedKLRS realized, solidRANI realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

KLRSKalaris Therapeutics, Inc.

2.00▼−6.10%· post 2.04

Mkt cap$48.3MRevenue—

RANIRani Therapeutics Holdings, Inc.

0.60▼−1.49%· post 0.60

ClosedOct 30 '26

Mkt cap$82.2MRevenue$2MQ2 FY26

Compare

ClosedOct 30 '26

KLRSKalaris Therapeutics, Inc.

RANIRani Therapeutics Holdings, Inc.

2.00▼−6.10%post 2.04

Price

0.60▼−1.49%post 0.60

$48.3M

Mkt cap

$82.2M

—

Revenue

$2MQ2 FY26

KLRS2.00▼−6.10%vsRANI0.60▼−1.49%ClosedOct 30 '26